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In prokaryotic systems, the initiation phase of protein synthesis is
governed by the presence of initiation factors that guide the
transition of the small ribosomal subunit (30S) from an unlocked
preinitiation complex (30S preIC) to a locked initiation complex
(30SIC) upon the formation of a correct codon–anticodon interaction
in the peptidyl (P) site. Biochemical and structural characterization
of GE81112, a translational inhibitor specific for the initiation phase,
indicates that the main mechanism of action of this antibiotic is to
prevent P-site decoding by stabilizing the anticodon stem loop of
the initiator tRNA in a distorted conformation. This distortion stalls
initiation in the unlocked 30S preIC state characterized by tighter IF3
binding and a reduced association rate for the 50S subunit. At the
structural level we observe that in the presence of GE81112 the h44/
h45/h24a interface, which is part of the IF3 binding site and forms
ribosomal intersubunit bridges, preferentially adopts a disengaged
conformation. Accordingly, the findings reveal that the dynamic
equilibrium between the disengaged and engaged conformations
of the h44/h45/h24a interface regulates the progression of protein
synthesis, acting as a molecular switch that senses and couples the
30S P-site decoding step of translation initiation to the transition
from an unlocked preIC to a locked 30SIC state.
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The majority of known antibiotics target the translational ap-paratus (1–4), but very few (e.g., kasugamycin, edeine, pacta-
mycin, thiostrepton) are inhibitors of the initiation phase of protein
synthesis, and even fewer display specificity for either the target or
the kingdom of life in which they are effective (2–8). Two notable
exceptions are Furvina (9) and GE81112 (6, 10), which inhibit
bacterial protein synthesis by interfering with initiator fMet–tRNA
binding to the 30S ribosomal subunit, thereby preventing the for-
mation of the 30S initiation complex (30SIC).
Bacterial initiation progresses through a series of kinetic
checkpoints that determine the overall efficiency and fidelity of
translation initiation of a given mRNA (11–13). The initial step
involves the recruitment of initiation factors (IFs) IF1, IF2·GTP,
and IF3, mRNA, and fMet–tRNA to the 30S subunit that leads to
the formation of the 30S preinitiation complex (30S preIC) in
which initiator tRNA and mRNA are both ribosome-bound but
not mutually interacting (12). Subsequently, a first-order isomeri-
zation of the 30S preIC leads to peptidyl (P)-site codon–anticodon
pairing and yields a “locked” 30SIC. This 30S preIC→30SIC
transition represents the first kinetic checkpoint of translational
fidelity, because this process is under the kinetic control of the IFs,
and during this step IF3, assisted by IF1, “inspects” the correctness
of the 30S ligands, in particular the tRNA anticodon stem loop
(ASL) and the mRNA start codon; any complex containing non-
canonical components or having a geometry unfavorable for
docking to the 50S ribosomal subunit is preferentially dissociated
by IF3. The subsequent subunit-association step and the con-
comitant ejection of the IFs occur very rapidly only if the 30SIC
contains canonical ligands and is geometrically fit for successful
docking by the 50S. The subunit association step itself and the
subsequent initial events that mark the 30SIC→70SIC transition
until IF3 and IF1 are dissociated and the 70S complex stabilized
represent the second and third kinetic checkpoint, respectively.
Together they allow only a correctly formed 30SIC to proceed into
the elongation phase of translation (11–14).
GE81112 (6, 10) is a highly hydrophilic chlorine-containing,
noncyclic, nonribosomal tetrapeptide constituted by four non-
proteinogenic L-amino acids. It is found in nature in three struc-
tural variants (A, B, and B1 with molecular masses of 643–658
Da). The most active of these variants proved to be variant B (658
Da), which was used throughout this study and whose structure is
shown in Fig. S1. Fourteen biosynthetic genes (getA–N) involved
in the synthesis of GE81112 have been identified within a larger
Significance
Eubacterial protein synthesis entails formation of an unlocked
preinitiation complex consisting of the 30S ribosomal sub-
unit, initiation factors, mRNA, and initiator tRNA. A confor-
mational change in the subunit accompanies mRNA–tRNA
codon–anticodon base-pairing generating a locked 30S complex.
If correctly formed, this complex associates with the 50S ribo-
somal subunit forming a 70S complex, and the initiation factors
are ejected. We show that the translational inhibitor GE81112
targets this essential step, hampering formation of a canonical
codon–anticodon interaction and stalling the 30S in an unlocked
state. Moreover, in the presence of GE81112 three rRNA helices,
h44/h45/h24a, are stabilized in a disengaged conformation, sug-
gesting that their conformation is associated with tRNA/mRNA
decoding and transition of the 30S from unlocked to locked state.
Author contributions: A.F., L.B., T.K., A.M.G., C.T., S.Y., S.R.C., C.O.G., and P.F. designed
research; A.F., A.S., L.B., T.K., A.M.G., R.G., B.O.-L., C.T., S.R.C., and C.O.G. performed
research; A.F., C.T., S.R.C., C.O.G., and P.F. contributed new reagents/analytic tools; A.F.,
A.S., L.B., T.K., A.M.G., S.R.C., C.O.G., and P.F. analyzed data; andA.S., T.K., C.T., S.R.C., C.O.G.,
and P.F. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Data deposition: Crystallography, atomic coordinates, and structure factors reported in
this article have been deposited in the Protein Data Bank (PDB) (ID code 5IWA).
1A.F., A.S., L.B., and T.K. contributed equally to this work.
2Present address: Department of Physical Biochemistry, Max Planck Institute for Biophys-
ical Chemistry, 37077 Gottingen, Germany.
3To whom correspondence may be addressed. Email: sean.connell@gmail.com, claudio.
gualerzi@unicam.it, or pfucini@gmail.com.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1521156113/-/DCSupplemental.
E2286–E2295 | PNAS | Published online April 6, 2016 www.pnas.org/cgi/doi/10.1073/pnas.1521156113
biosynthetic gene cluster, which has been cloned from Streptomy-
ces sp. L-49973, sequenced, and partially characterized (15). Be-
cause it belongs to a structurally unique class of antibiotics and
inhibits an underexploited target within the translational appara-
tus, GE821112 seems to be a promising pharmacophore from
which one could derive a new class of anti-infective agents for
which no resistance has yet developed in nature.
The aim of this work is to characterize the ribosomal binding
site of GE81112 and gain a deeper understanding of the mech-
anism by which P-site binding of the initiator tRNA is inhibited
by this molecule. By combining biochemical and structural
methods, we aim to understand the action of GE81112 within the
context of the translational initiation pathway.
Results
X-Ray Diffraction Studies Show That GE81112 Stabilizes the P Site ASL
in a Distorted Conformation and Prevents the Formation of a Codon–
Anticodon Interaction.After ascertaining that GE81112 can inhibit
fMet–tRNA binding to Thermus thermophilus 30S ribosomal sub-
units, X-ray crystallography of the T. thermophilus 30S-GE81112
complex was used to obtain high-resolution structural information
on the binding site of the antibiotic (Fig. 1) and to understand the
molecular basis of its mechanism of action. The initial Fo-Fc dif-
ference map showed a region of positive density in a position where
the tip of the spur (h6) of a symmetry-related 30S subunit packs
into the P site, mimicking the ASL of P-site–bound tRNA (Fig. 1 A
and B and Fig. S2A) (16–19). To facilitate interpretation and fur-
ther improve the quality of the difference maps, we used a bulk
solvent modeling protection approach (20, 21) that prevents
uninterpreted regions of interest from being incorporated into the
solvent mask (Materials and Methods).
Analysis of the resulting maps indicates that GE81112 binds in
a pocket formed by the C-terminal tail of S13, the distorted tip of
the ASL mimic, the tip of h44 (C1400), and the loop of h31
(G960) (Figs. 1D and 2A). Accordingly, in the T. thermophilus
30S subunit, the accommodation of the drug in this pocket in-
volves (i) the ordering of the flexible C-terminal tail of S13,
which is generally disordered in the structures of the T. ther-
mophilus 30S subunits but sometimes is seen between the A- and
P-tRNAs (22, 23), and (ii) the stabilization of a conformational
change in the ASL mimic. With regard to the S13 tail, residues
K120–R125 become ordered so that they can be putatively
modeled within the electron density (Fig. 1C). However, this
ordering in the presence of GE81112 may play a role in only
a subset of bacterial species, because in T. thermophilus the
C-terminal tail of S13 (126 aa) is extended relative to that in
Escherichia coli (118 aa). As seen in Fig. 1 C and E, although the
ligand GE81112 and S13 can be putatively modeled into the
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Fig. 1. GE81112 binds in the ribosomal P site and distorts the ASL mimic. (A) An overview showing the binding site of GE81112 on the 30S subunit with the
relevant 16S rRNA helices labeled. (Inset) Two symmetry-related 30S subunits are packed in the crystal such that h6 (blue) of one 30S subunit (red) inserts into the
P site of a second subunit (gray) to mimic a P-tRNA. h6 in both subunits is circled. (B) Two orthogonal views of the ASL mimic showing a shift of the backbone
between the 30S apo and 30S-GE81112 conformations (red and blue, respectively). Note that U81–U84 of the ASLmimic correspond to U33–U36 in the anticodon
loop of the initiator tRNA. The initial unbiased positive Fo-Fc map is contoured at 4 σ (green mesh). (C) The C-terminal tail (K121–R125) of T. thermophilus S13,
generally disordered and not visible in 30S crystal structures, becomes structured in the presence of GE81112. The Fo-Fc map is shown. (D) GE81112 is modeled in
a binding pocket between S13 and the distorted ASL. (E) Fo-Fc map in the ASL and GE81112 region (Inset) with a zoom-in on the GE81112 electron densities
where the ASL density is masked out for clarity. Maps in C and E are rendered at 3 σ and used the bulk solvent modeling protection approach (21).
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electron density, it is not possible at the resolution of the map to
distinguish the last C-terminal residues of S13 unambiguously
from the four nonproteinogenic amino acid moieties of GE81112,
and therefore alternative arrangements are possible. The limited
possibilities for the drug to interact with the 16S rRNA in its
pocket explain why the RNA-probing experiments to determine
the GE81112 localization on the 30S subunit have been incon-
clusive (see Fig. S7 and ref. 6).
Taken together, these results indicate that upon binding to the
30S subunit GE81112 occupies a position corresponding to the P-site
tRNA and stabilizes a conformational change of the ASL. In fact,
GE81112 would overlap with the ASL, as observed in the apo30S,
and the residues forming the ASL tip (U81–A85) are displaced
relative to the position that they occupy in the native 30S crystals. In
particular, the phosphate backbone of U82 and U83, which corre-
spond to and hereafter are referred to as “C34” and “A35” of the
initiator tRNA anticodon (Fig. S2A), are shifted by ∼9 Å (Fig. 1B).
C34 and A35 decode the third and second positions of the AUG
start codon, and their displacement, as seen in the GE81112
ribosomal complex, would preclude them from forming a correct
codon–anticodon interaction with the mRNA (Fig. S2B). This
significant conformational change of the ASL tip is allowed be-
cause the ribosome does not monitor or interact directly with the
P-site tRNA anticodon aside from a stacking interaction between
the third position of the codon–anticodon duplex and C1400/G966
of 16S rRNA (17). The conformation of the remaining residues of
the ASL mimic that contact the 30S subunit near h24a (A790) and
h42 (1338–1339) (Fig. 2A) is changed only slightly in the presence
of GE81112.
The Presence of GE81112 and Absence of P-Site Codon–Anticodon
Interaction Stabilizes the h44/h45/h24a Interface in the Disengaged
Conformation. The electron density map of the 30S·GE81112
complex reveals that, in addition to the effects on the structure of
the ASL mimic and the consequent impairment in the formation
of a codon–anticodon interaction in the P site, the interface of
h44, h45, and h24a also undergoes a substantial conformational
switch (Fig. 2). Here the highly conserved GGAA tetraloop of h45
(G1516–A1519) is observed in two alternative conformations: a
weaker engaged conformation (Fig. 2B) characterized by a po-
tential hydrogen bond network between h45 (G1517–A1519) and
h44 (C1496–1497) and a predominant disengaged conformation
(Fig. 2C) in which the h45 loop withdraws from h44, disrupting the
hydrogen bond network (compare Fig. 2 B and C). The withdrawal
of the h45 loop is brought about by a conformational change that
shifts G1517 and A1518 by 4.5 and 4.7 Å, respectively, disrupting
the internal hydrogen bonds that close the GGAA tetraloop. The
shift of A1518 brings the dimethylated N6 of this base into the
proximity of U793 (h24a) so that the latter base is shifted (Fig. 2 B
and C), in turn causing a slight perturbation of the positions of the
neighboring bases A792 and A794. These conformational changes
are consistent with DMS probing experiments (6) that showed that
the reactivity of bases in h24a (A792, C795, and C796) is altered
by GE81112 binding.
GE81112 Inhibits the Formation of a Locked 30SIC. To understand
how the structural changes described above play a role in the
translational initiation pathway, we used fluorescence stopped-
flow analysis and rapid nitrocellulose filtration to quantify the
effect of GE81112 on the kinetics of fMet–tRNA binding to 30S
ribosomal subunits. In the first approach the increase in the FRET
signal generated by the proximity of fMet–tRNA8-fluo (acting as
donor) and IF3166-ALEXA555 (acting as acceptor) is recorded as
a function of the time elapsed after mixing the fluorescent initi-
ator tRNA with mRNA-programmed 30S subunits bearing IF1,
IF2·GTP, and fluorescent IF3. No effect of the antibiotic on the
fMet–tRNA binding kinetics was detected in these experiments,
even at a very high antibiotic concentration (100 μM), because
superimposable tracings were obtained in the presence or absence
of GE81112 (Fig. 3A). Similar results were obtained when the
antibiotic was preincubated with the 30S subunits or offered to the
subunits together with fMet–tRNA. Furthermore, no GE81112 in-
hibition of the ribosomal binding of fMet–tRNA could be seen when
the binding kinetics was monitored using IF14-ALEXA555 as the FRET
acceptor (Fig. S3A) or by the quenching of the IF2757-ALEXA488
fluorescence by the approaching fMet–tRNA8-QSY35 (Fig. S3B).
Because these experiments monitor the initial binding of fMet–
tRNA to mRNA-programmed 30S ribosomal subunits to form a
30S preIC, it can be concluded that the antibiotic has no effect
on this early step of the translation initiation pathway. How-
ever, when the binding kinetics were analyzed by rapid filtra-
tion, a method that detects the formation of a “locked” 30SIC
produced by a first-order isomerization of the 30S preIC (12, 13),
a clear inhibition of fMet–tRNA binding by even low (1.5 μM)
concentrations of GE81112 was observed (Fig. 3B). These results
indicate that GE81112 interferes with the isomerization of the 30S
complex that leads to a stable interaction between mRNA and
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Fig. 2. Overview of conformational changes observed in the 30S subunit in
the presence of GE81112. (A) In the GE81112 ribosomal complex, several 16S
rRNA residues assume alternative conformations. At the interface of h24a
(light blue) and h45 (orange) residues U793, A1519, A1518, G1517, and
G1516 are colored red and are drawn in the alternative conformation
unique to the GE81112 structure. Similarly residues U81–A85 of the ASL are
colored red and drawn as seen only in the presence of GE81112. Note that
residues G1491–A1493, although not in an alternative conformation, show
significant disorder. The crystallographic refinement indicates that the resi-
dues of the ASL, h24a, and h45 that are colored red have occupancies of
about 60% and 40%, corresponding to the conformations seen in the
presence and absence (PDB ID code 2ZM6) of GE81112. S13 was omitted,
because it is not likely to be involved in GE81112 binding in all bacterial
species. (B and C) Key residues at the interface of h44/h45/h24a are illustrated in
the engaged (B) and disengaged (C) conformation. Although both conforma-
tions are observed in the presence of GE81112, the disengaged conformation
is predominant in the presence of GE81112, and the engaged conformation is
predominant in the apo30S subunits (PDB ID codes 2ZM6 and 1J5E).
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initiator tRNA and marks the transition from the 30S preIC to the
30SIC (Fig. 3C).
This locking step is under the kinetic control of IF3 and IF1
and depends upon the nature of the 30S ligands (canonical vs.
noncanonical) (12, 24). Therefore, experiments were carried out
to investigate if the inhibition by GE81112 might be accompa-
nied by an altered interaction of the IFs with the ribosome and to
determine if the inhibition of 30SIC formation might depend
upon the nature of the 30S ligands, as is the case for the other
powerful P-site inhibitor Furvina, whose inhibition displays ini-
tiation codon bias (9).
The results of these experiments demonstrated that GE81112
inhibits 30SIC formation (Fig. S4A) (25, 26) and mRNA transla-
tion (Fig. S4B) to the same extent, regardless of the canonical or
noncanonical nature of the start codon (AUG and AUU, re-
spectively) and the presence or absence of a 5′ UTR (leadered
and leaderless mRNA, respectively). Furthermore, the forma-
tion of a “pseudoinitiation complex” in which the fMet–tRNA
analog NAc–Phe–tRNA is bound to poly(U)-programmed 30S
ribosomal subunits (27) was found to be inhibited by GE81112,
albeit at an antibiotic concentration ∼60-fold higher than that nec-
essary to inhibit fMet–tRNA binding to the same extent (Fig. S4C).
Thus, the inhibition by GE81112 is neither codon nor amino acid–
tRNA specific. Taken together, these results indicate that GE81112
and Furvina inhibit P-site binding of initiator tRNA by different
mechanisms and that the target of GE81112 inhibition is not a par-
ticular ribosomal ligand but instead is the molecular mechanism that
underlies the locking step allowing the 30S preIC→30SIC transition.
GE81112 Stabilizes an Altered Ribosomal Positioning of IFs, fMet–
tRNA, and mRNA. Because the structural results indicated that
GE81112 stabilizes the ASL of the P-site substrate in an altered
conformation, we tested the in situ accessibility of fMet–tRNA
and mRNA to hydroxyl radical cleavage within the 30SIC in the
presence and absence of the antibiotic. In the absence of GE81112
the cleavage pattern of 30SIC-bound fMet–tRNA displays typical
features of ribosome-bound tRNA. In particular, bases G29, G30,
and G31 are strongly protected from cleavage (Fig. 4A, lanes 7 and
8, and Fig. 4 B andC). These protections presumably are caused by
the extensive interactions occurring between the consecutive GC
pairs of the ASL and the universally conserved nucleotides G1338
and A1339 of 16S rRNA that line one side of the P site (17, 28).
Additional interactions that may contribute to the observed pro-
tection are those involving the sugar–phosphate backbone of nu-
cleotides A1229–C1230 of 16S rRNA and possibly the C-terminal
tail of S13 (17, 28). However, these protections are partially lost in
the complex formed in the absence of mRNA (Fig. 4A, lanes 5 and
6) and in the presence of increasing amounts of GE81112 (Fig. 4A,
lanes 9–12), as evidenced by the ratios of intensities of the elec-
trophoretically resolved bands (Fig. 4B). In comparison with these
effects, the changes in accessibility induced by the antibiotic in the
anticodon region are more difficult to detect because of the in-
trinsic susceptibility of this portion of the tRNA molecule to
spontaneous cleavages. Thus, although electrophoretically puri-
fied, intact tRNA was used in these experiments, the anticodon
loop and other single-stranded regions of the tRNA underwent
spontaneous hydrolysis, and fragments derived from cleaved tRNA
were again produced (Fig. 4A, lanes 1 and 2). The repeated, harsh
phenol-chloroform-SDS extractions necessary to remove the ri-
bosomal proteins that could interfere with the subsequent elec-
trophoretic separation also worsen the situation. Nevertheless,
although bands generated by these spontaneous cleavages con-
tribute to increasing the background of the bands produced
by hydroxyl radical cleavage and partly mask the effects of the
30S pre-IC A B 
C D 
30S-IC 
70S-IC 
Fig. 3. Inhibition of 30SIC and 70SIC formation by GE81112. (A) Kinetics of 30S preIC formation in the presence (red tracing) and absence (black tracing) of
100 μM GE81112. The ribosomal binding kinetics of fMet–tRNA were followed with a fluorescence stop-flow apparatus making observable the FRET signal
generated by the proximity of fMet–tRNA8-fluo, acting as a donor to IF3166-ALEXA555. (B) Kinetics of locked 30SIC formation in the absence (red trace) or in the
presence (black trace) of 1.5 μM GE81112. Binding of f[35S]Met-tRNA to 022 mRNA-programmed 30S subunits to form a 30SIC were measured by rapid ni-
trocellulose filter binding as described (29). (C) Schematic representation of the 30S preIC complex→30SIC transition. In the 30S preIC complex both mRNA and
initiator tRNA are ribosome-bound, but no proper codon–anticodon interaction takes place. A subsequent locking step (inhibited by GE81112) entails P-site
codon–anticodon base-pairing that stabilizes the mRNA–initiator tRNA interaction yielding a 30SIC. (D) Stopped-flow kinetics of a 50S subunit docking to
30SIC to produce a 70SIC in the absence (black tracing) or presence (red tracing) of 100 μM GE81112. The association of the 50S subunits with a 30SIC was
monitored using the variation in the light-scattering signal as an observable. a.u., arbitrary units.
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antibiotic, a GE81112-induced increased exposure of the anticodon
region is visible upon inspection of the gel (Fig. 4A, compare
lanes 7 and 8 with lanes 9–12). The effects caused by GE81112
are even more clear when the ratios of the band intensities observed
in the presence and absence of the antibiotic are determined. Fig. 4
B and C displays plots of the ratios of the intensities of the
Fig. 4. Accessibility to hydroxyl radical cleavage of fMet–tRNA in the 30S complexes formed with and without GE81112. (A) Electrophoretic migration of
uncleaved (lanes 1 and 2) or hydroxyl radical-cleaved (lanes 3–12) [32P]fMet–tRNA in the unbound form (lanes 3 and 4), within a 30S complex lacking mRNA
(lanes 5 and 6), within a complete 30SIC without GE81112 (lanes 7 and 8), or within a complete 30SIC with increasing amounts (i.e., 1.5, 12, 25, and 50 μM) of
GE81112 (lanes 9–12). The L and ΔT1 lanes correspond to the ladders obtained upon alkaline hydrolysis and RNaseT1 digestion of tRNA, respectively. The
intensity of the bands obtained upon cleavage in the absence (lanes 7 and 8) or in the presence of 1.5 (black), 12 (blue), 25 (red), and 50 μM (purple) of
GE81112 (lanes 9–12) were quantified by densitometry. (B and C) The ratios of the intensities obtained with and without GE81112 are plotted; the anticodon
bases are indicated in red. The ratios were calculated using the absolute intensity values (B) or the intensities after subtraction of the averaged intensities of
the bands of lanes 1 and 2 considered to represent the spontaneously cleaved background (C). The intensities ratio of U33 could not be calculated. Because of
the different extents of the recorded effects, the scales of the ordinate for bases G41–C32 and for G31–G22 are different in both plots. (D) Primer extension
analysis of the 002 mRNA sites cleaved by hydroxyl radicals in the presence and absence of GE81112. Uncleaved mRNA (lane 1), mRNA cleaved in the unbound
form (lanes 2 and 3) and with a complete 30SIC assembled in the absence (lanes 4 and 5) or in the presence of 0.5 (lanes 6 and 7), 1.5 (lanes 8 and 9), 12 (lanes
10 and 11), 25 (lanes 12 and 13), and 50 μM (lanes 14 and 15) GE81112. Lanes C, T, A, and G are the sequencing ladders. (E) Plot of the ratio of the den-
sitometrically quantified, averaged intensities of bands 6,7/4,5 (black); 8,9/4,5 (blue); 10,11/4,5 (green); 12,13/4,5 (red), and 14,15/4,5 (purple). The SD sequence
(green) and the initiation codon AUG (red) are indicated. (F) 3D structure of fMet–tRNA–mRNA interaction (PDB ID code 1YL4) highlighting the tRNA and
mRNA regions that are more (red) or less (blue) exposed to cleavage in the presence of GE81112. Further details are given in Materials and Methods.
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individual bands before (Fig. 4B) and after (Fig. 4C) subtraction of
the band intensities of lanes 1 and 2 that are assumed to represent a
background insofar as they indicate the approximate extent of the
spontaneous cleavages occurring in the tRNA used to form the
complexes. In conclusion, these experiments give a clear indication
that the bases of the anticodon loop, C34 and A35 in particular,
become more exposed in the presence of GE81112, in full
agreement with the aforementioned effects observed by crystal-
lography (Fig. 2A).
30S-mRNA Interaction.GE81112 was shown to have only a marginal
effect on the binding kinetics of either 5′ leadered (Fig. S5C) or
leaderless (Fig. S5D) mRNA to the 30S subunit. However, the
antibiotic had profound effects on the accessibility of 30S-bound
mRNA to hydroxyl radical cleavage. Both protection and exposure
in the presence of GE81112 were observed with 002 mRNA (Fig.
4 D and E), 003 mRNA (Fig. S6A), and 022 mRNA (Fig. S6B),
three model mRNAs that differ in the length of the SD sequence
and spacer (29). The cleavage pattern indicates that the bases of the
SD region are more exposed when GE81112 is present (Fig. 4 D
and E and Fig. S6A). Furthermore, GE81112 makes the first base of
the start codon of 002 mRNA (Fig. 4 D and E) and 003 mRNA
(Fig. S6B) more accessible. The effect on the start codon of 022
mRNA can be hardly detected, because this mRNA region is
strongly protected by the 30S subunit under all conditions (Fig.
S6A). In addition to the aforementioned increased exposures, some
regions of the mRNAs, both upstream and downstream of the
initiation triplet, become more protected in the presence of
GE81112 (Fig. 4 D and E). Understandably, the cleavage pattern
in the 5′ region upstream of the start codon is different in the
three different mRNAs and reflects the different natures and
strengths of their interaction with the 30S subunit, possibly resulting
from the different lengths of their SD sequences (29, 30).
Overall, these findings indicate that although fMet–tRNA and
mRNA are also ribosome-bound in the presence of GE81112,
they occupy noncanonical positions on the 30S subunit so that
the interactions between the fMet–tRNA and P site, between the
mRNA and 30S subunit, and between the fMet–tRNA and
mRNA start codon are either lost or weakened in the presence
of the antibiotic (Fig. 4F). This conclusion is confirmed by the
finding that IF3 is more tightly bound to the 30S complex con-
taining GE81112, because it is exchanged more slowly with the
unbound factor (Fig. 5A). Indeed, although IF3 does not disso-
ciate from the 30S subunit until the docking of the 50S is com-
plete, formation of a canonical 30SIC weakens its affinity for the
30S subunit, but the affinity remains high when the complex
formed is not canonical (24, 31). In contrast to IF3, neither IF1
nor IF2 is more tightly bound to the 30S subunit in the presence
of GE81112 (Fig. S5 A and B). Additional evidence for the
noncanonical structure of the 30S complex formed in the pres-
ence of GE81112 is its slower docking with the 50S ribosomal
subunits (Fig. 3D) and the slower dissociation of the three IFs
during the 30SIC→70SIC transition; the rates of IF1 (Fig. 5B)
and IF3 (Fig. 5D) dissociation are reduced approximately two-
fold, whereas the rate of IF2 dissociation is reduced approxi-
mately six-fold (Fig. 5C).
The in situ hydroxyl radical cleavages of 16S rRNA are con-
sistent with the premise that GE81112 affects the conformation
of the 30S subunit. The results of these experiments indicate that
GE81112 has generalized effects on the head and platform of the
30S subunit (Fig. S7) that indicate extensive GE81112-induced
conformational changes in the subunit.
Discussion
Together with Furvina, GE81112 probably is the most effective
and specific inhibitor of the bacterial initiation phase of protein
synthesis known thus far (6, 9). Because previous studies have
shown that GE81112 interferes with the P-site function of the
30S ribosomal subunit, in this study we examined in more depth
the mechanism by which this inhibition takes place using a bio-
chemical and structural approach. The data presented here
demonstrate that GE81112 does not inhibit the initial binding of
fMet–tRNA and mRNA to the 30S ribosomal subunit that yields
a 30S preIC; namely, it allows the formation of a complex in
which both ligands are ribosome-bound but do not interact stably
with each other (12). However, the antibiotic interferes with the
subsequent step, namely the first-order isomerization of the 30S
complex that marks the transition of 30S preIC to 30SIC (12).
Thus, it seems clear that the mechanism of action of GE81112 is
different from that of Furvina, which inhibits the initial binding
of fMet–tRNA that yields a 30S preIC complex (9). Further-
more, unlike Furvina (9), inhibition by GE81112 is not biased by
the nature of the initiation codon, tRNA or mRNA.
The present data indicate that a 30S complex formed in
the presence of GE81112 is characterized by a “non–best-fit”
structure, as shown by IF3 remaining more tightly bound and the
complex being docked more slowly by the 50S subunit to form a
70SIC with a corresponding decrease in the rate at which all
three IFs are dissociated during this process. At the molecular
level, it was observed that GE81112 binds into a pocket within
the P site near the tip of the ASL mimic, stabilizing residues
corresponding to C34 and A35 of initiator tRNA in an altered
conformation, away from the canonical codon position. Thus, it
is possible to conclude that the primary mechanism by which
GE81112 inhibits 30SIC formation is through the stabilization of
a distorted conformation of the anticodon loop of the initiator
tRNA so that it loses, at least partially, the possibility to form a
canonical codon–anticodon interaction with the AUG start co-
don (Fig. 1B and Fig. S2). The latter premise is supported by the
results of in situ probing the accessibility of fMet–tRNA and
mRNA to hydroxyl radical cleavage (Fig. 4). Aside from this
Fig. 5. Ribosomal affinity and dissociation of the IFs in the presence of
GE81112. (A) Rate of exchange between fluorescent 30S-bound and non-
fluorescent free IF3 in the presence (red tracing) and absence (black tracing)
of GE81112. The dissociation of IF3 was determined from the rate of ex-
change measured by a fluorescence stopped-flow apparatus monitoring the
decrease of fluorescence intensity of IF3166-ALEXA555 upon the addition of a
10-fold excess of nonfluorescent factor. (B–D) Dissociation of the IFs upon
association of 30SIC with 50S subunits during the 30SIC→70SIC transition in
the presence (red tracing) and absence (black tracing) of GE81112. The dis-
sociation of IF1 (B) and IF3 (D) from 30SIC complexes containing an Alexa
555-labeled factor, and fluorescein-labeled fMet–tRNA was monitored by
the decrease in the FRET signal between the two fluorophores. (C) The
dissociation of IF2 was monitored by an increase in the fluorescence
resulting from the reduced quenching caused by the loss of proximity be-
tween IF2757-ALEXA488 and fMet–RNA8-QSY35.
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effect on codon–anticodon pairing and on the accessibility of one
side of the anticodon stem (Fig. 4 A–C), the remaining interac-
tions of the tRNA with the ribosomal P site are mostly unaffected
by the drug (Fig. 2A and Fig. S8A), explaining why, in the presence
of GE81112, fMet–tRNA can bind to the 30S subunit and form a
30S preIC (Fig. 3A) and why the tRNA cleavage pattern displays
the typical features of ribosome-bound tRNA (Fig. 4A).
In addition to the distortion of the ASL tip, the GE81112
complex shows conformational changes of the ribosomal subunit
(Fig. S7), the most relevant of which involves the highly con-
served GGAA tetraloop of h45 (G1516–A1519). In this region of
the 16S rRNA GE81112 favors the disengaged over the engaged
configuration of the h44/h45/h24a interface (Fig. 2). Previous
studies have shown that in the apo30S subunit the h44/h45/h24a
interface is flexible and can exist in two alternative conforma-
tions, i.e., engaged and disengaged (32). Switching between these
two conformations alters the hydrogen bonding network between
h24a, h45, and h44 (Fig. 2 B and C), and minimal alterations in
the elements present in this region of the ribosome can stabilize
one form or the other. Indeed, transitions between the engaged
and disengaged conformations of h44/h45/h24a have been ob-
served in the crystal structure of the 30S-lacking dimethyl groups
on A1518 and A1519 (i.e., a ksgA− mutant) and, more recently,
in the presence of aminoglycoside antibiotics, near-cognate A-site
mimics and rRNA mutations in fully methylated 30S subunits
(18, 32, 33). On the other hand, in the 70S ribosome h44/h45/h24a
elements take part in the formation of the intersubunit bridges
B2a, B2b, and B3 and, unlike in the 30S subunit, only the engaged
conformation has been observed on the 70S (Fig. S9) (34–39).
Comparison of the h44/h45/h24a interface conformation in the
presence and absence of GE81112 suggests that although the
correct P-site positioning of mRNA and initiator tRNA favors
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Fig. 6. Structural model on the initial phase of translation initiation and the effect of GE81112 during the transition of a preIC to a 30SIC. (A) Overview on
the interaction of the three IFs on the 30S subunit as observed in the cryo-EM structure of a 30S in complex with IF1 (green), IF2 (yellow), IF3 (magenta),
P-tRNA (blue), and mRNA (60). (B) Zoom-in on the binding site of IF1 and IF3, near helices h44 (light green), h23 (pale blue), h24a (cyan), and h45 (orange) of 16S
rRNA; the residues that acquire an alternative conformation in the presence of GE81112 are in red. (C) Scheme illustrating the molecular events suggested by
the findings of the present study. (Left) A 30S preIC containing the three IFs and a not yet base-paired initiator tRNA and mRNA bears a flexible h44/h45/h24a
interface. (Upper Center) If tRNA and mRNA are canonical, P-site decoding occurs to yield a bona fide 30SIC in which the h44/h45/h24a interface is engaged
(locked). (Right) The affinity of this complex for IF3 is reduced, and the complex is amenable for docking by the 50S subunit and for undergoing 30SIC→70SIC
transition with concomitant dissociation of the three IFs. (Lower Center) If the ligands in the 30S preIC are noncanonical or if GE81112 (or streptomycin)
is present, a structurally faulty complex 30SIC* is formed in which proper codon–anticodon interaction does not occur. This complex contains a disengaged
h44/h45/h24a structure, binds IF3 more tightly, and is unsuitable for docking with 50S subunits. Further details can be found in the text.
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the formation of the engaged conformation, the noncanonical po-
sitioning of these ligands, or their absence, stabilizes the alternative
disengaged conformation of h44/h45/h24a (Fig. 2 and Fig. S8). This
finding and the fact that the primary target of GE81112 inhibition is
the 30S preIC→30SIC transition suggest that the first-order isom-
erization that underlies this transition entails a shift of the h44/h45/
h24a interface from the disengaged to the engaged conformation.
The present data also suggest that the conformational transition
of the h44/h45/h24a interface represents a molecular device for
monitoring the P-site decoding function whereby the correct
accommodation of fMet–tRNA and mRNA in the P site is
sensed by the acquisition of the engaged conformation in the
h44/h45/h24a interface and is transmitted to the subsequent
steps of the initiation phase (Figs. 2 and 6 and Fig. S8).
Furthermore, the available data suggest that the conforma-
tional switch of h44/h45/h24a also could be monitored by IF3 in
its fidelity function. In particular, we suggest that the switch in
IF3 affinity for the 30S subunit that marks the 30S preIC→30SIC
transition may depend upon the h44/h45/h24a conformation. In-
deed, compared with the canonical 30SIC, IF3 displayed a tighter
binding to the faulty 30S complex formed in the presence of
GE81112 in which the h44/h45/h24a interface is predominantly in
the disengaged conformation; its affinity for the 30S subunit is
somewhat lower in the canonical 30SIC (24, 31). In this context it
should be recalled that previous structural and biochemical studies
indicate that there is a physical proximity between the IF3 binding
site and the h44/h45/h24a interface and that the IF affects the
structure of this region. In fact, binding of IF3 disrupts a crosslink
between U793 (h24a) and G1517 (h45) (40), two bases that,
together with A1518, are among the residues with highest con-
formational variability during the disengaged→engaged transition
(Fig. 2 and Fig. S8). Furthermore, 16S rRNA probing using hy-
droxyl radicals (41), 1-cyclohexyl-(2-morpholinoethyl) carbodiimide
metho-p-toluenesulfonate (CMCT) (42), and kethoxal (43)
showed that IF3, in addition to protecting G700 and G703 (in
h23b) completely, also protects G791 and U793 in h24a. Likewise,
binding of IF3C, the domain of the factor capable of performing
all the activities of intact IF3 (44), protects bases in h23b and
exposes other h24a bases (e.g., 783, 784, 790, and 794) flanking
h45 (45). Finally, the point mutations A790G, U789C, and G791A
in h24a were found to alter both the ribosomal affinity and fidelity
functions of IF3 (46, 47).
In conclusion, in light of the present findings and of a large
body of published data, we propose the mechanism schematically
presented in Fig. 6C. Namely in the 30S preIC the disengaged
and engaged conformations of the h44/h45/h24a interface are in
a dynamic equilibrium, so that in the absence of P-site codon–
anticodon interaction, as observed in the 30S–GE81112 complex,
the disengaged form prevails. In contrast, upon proper accom-
modation of mRNA and P-site tRNA, h44/h45/h24a instead
adopts the engaged conformation. IF3 and IF1 favor the for-
mation of the disengaged conformation, unless the h44/h45/h24a
conformation is switched to the engaged conformation by the
presence of canonical 30S ligands and proper P-site codon–
anticodon interaction. In turn, this switch results in the weaken-
ing of the 30S–IF3 interaction and in a best-fit docking of the
50S subunit.
Materials and Methods
Preparation of mRNAs and Translational Tests. The 022, 003, and 002 mRNAs
(48) were prepared by in vitro transcription with bacteriophage T7 RNA
polymerase of a DNA template derived from the amplification of the cor-
responding E. coli coding genes cloned in pTZ18R using primers that anneal
to nucleotides 143–160 (forward primer 5′-GCTTCCGGCTCGTATGTTGTGTG-
3′) and 297–319 (reverse primer 5′-GTAAAACGACGGCCAGT-3′) of the vector
(25, 29). Translational tests were carried out as described (25, 29) using E. coli
ribosomes, ribosomal subunits, initiator tRNA, and translational factors
prepared as described (49).
Fluorescence-Labeling of IF1, IF2, IF3, and tRNAfMet. E. coli IF1, IF2, and IF3
genetically modified to introduce single cysteines were labeled essentially as
previously described (49). Reducing agents (i.e., 2-mercaptoethanol or DTT)
were removed by extensive dialysis at 4 °C against 50 mM Tris·HCl (pH 7.1)
buffer containing 100 mM NH4Cl and 0.1 mM EDTA. Disulfide bond for-
mation was prevented by 10-min treatment at 37 °C with a 10-fold molar
excess of Tris (2-carboxyethyl) phosphine hydrochloride (Sigma), a reducing
agent that does not compete with thiol modifications. Labeling was carried
out with a 20-fold molar excess of Alexa 488 or Alexa 555 (Invitrogen) as
appropriate. E. coli initiator tRNAfMet [65 A260 units/mL of 12 mM Hepes-KOH
(pH 8.2), containing 80% DMSO] was labeled at the thio-uridine in position 8
by 2-h incubation at 50 °C in the dark with 3.5 mM 50-IAF (iodoacetamide
derivatives of fluorescein). Labeling efficiency approached 100%. The re-
action was stopped by the addition of 0.3 M K-acetate (pH 5.0) and the la-
beled tRNAfMet was precipitated with 2.5 volumes of cold ethanol. For other
experiments tRNAfMet was labeled with the fluorescence quencher QSY-35
as described (49).
Kinetics of IF Dissociation from 30SIC. All experiments were carried out at
20 °C in a KinTek SF-2004 stopped-flow apparatus in 10 mM Tris·HCl (pH 7.7),
60 mM NH4Cl, 7 mM Mg acetate. The 30SIC complex was allowed to as-
semble at 37 °C for 10 min in the presence or absence of GE81112. The 30SIC
in syringe A contained 0.2 μM 30S subunits, 0.4 μM 022 mRNA, 0.5 mM GTP,
0.2 μM each of IF1, IF2, and IF3, one of which was fluorescently labeled
(IF1ALEXA555, IF3ALEXA555, or IF2ALEXA488), as specified in each case, and 0.4 μM
fMet–tRNAfluo. The kinetics of IF dissociation from 30S subunits was moni-
tored by promoting an exchange between fluorescent ribosome-bound and
free nonfluorescent factors. For these experiments syringe A was loaded
with the preformed 30SIC, and syringe B was filled with a single unlabeled IF
(as specified) in a 10-fold stoichiometric excess with respect to the corre-
sponding 30S-bound fluorescent IF. The kinetics of IF dissociation during
formation of the 70SIC was monitored upon mixing aliquots of preformed
30SIC in syringe A with equal volumes of 0.6 μM 50S in syringe B. The re-
actions were followed for the times indicated in each case.
Light Scattering. Equal volumes (20 μL) of 30SIC (0.2 μM) prepared as de-
scribed above, with or without 100 μM of GE81112 (syringe A) or 0.6 μM 50S
(syringe B) were allowed to mix at 20 °C in a stopped-flow apparatus.
Changes in light scattering were recorded by exciting at 430 nm and mea-
suring the scattered light at 90° with respect to the incident beam without a
filter. In a single experiment, 1,000 data points were acquired in logarithmic
sampling mode.
Table 1. Data collection and refinement statistics
Value
Data collection
Space group P41212
Cell dimensions
a, b, c, Å 413.14, 413.14, 173.63
α, β, γ, ° 90, 90, 90
Resolution, Å 160–3.50 (3.69–3.50)
Completeness, % 99.9 (99.6)
Rsym, % 16.5 (237.9)
I/σI 9.79 (1.46)
Multiplicity 11.3 (11.6)
Refinement
Resolution 3.5
No. of reflections 187167
Rwork/Rfree 16.9/21.7
Total no. of atoms 52,121
Ribosome 51,887
Ligand 46
Ions 188
Rmsd
Bond lengths, Å 0.019
Bond angles, ° 0.92
The dataset was obtained from three crystals. Values in parentheses refer
to the highest-resolution bin.
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tRNAfMet 5′-End Dephosphorylation and Labeling with 32P γ-ATP. The 5′ phos-
phate of tRNA was removed essentially as described (50) by mixing tRNA
(∼50 μg) with 0.6 U/μL calf intestinal alkaline phosphatase (CIAP) in 1× CIAP
buffer (Amersham). After 1-h incubation at 37 °C the dephosphorylated
tRNA was subjected to 10% PAGE in 8 M urea; the electrophoretically re-
solved band corresponding to the tRNA identified by UV254 nm shadowing
was excised, and the tRNA was eluted by shaking the gel slice overnight in
350 μL of elution buffer and 70 μL of phenol. The dephosphorylated tRNA
then was precipitated with three volumes of ethanol, resuspended in H2O,
quantified from its A260 nm, and stored at −80 °C. The dephosphorylated
tRNAfMet and tRNAfMet-fluo (2 μg) were 5′-end–labeled in 1× polynucleotide
kinase (PNK) buffer (Fermentas) with 15 units of PNK enzyme and 5 μL 32P
γ-ATP 3000 Ci/mmol for 75 min at 37 °C. The reaction was stopped by the
addition of 1/10 volume of 3 M Na acetate (pH 5.2) and three volumes of
cold absolute ethanol.
32P tRNAfMet and tRNAfMet-fluo Charging and Formylation. The labeled tRNAs
were charged with methionine in 150 μL of 10 mM Mg acetate, 30 mM
imidazole (pH 7.5), 6 mM 2-mercaptoethanol, and 100 mM KCl in the pres-
ence of 5 mM ATP, 5 mM phosphoenolpyruvate, 0.005 μg/μL methionine,
0.5 mM citrovorum factor, 0.06 μg/μL methionine transferase, and 0.03 μg/μL
formyl methionine transferase. At the end of the incubation, the labeled
fMet–tRNAs were subjected to phenol-chloroform extraction and pre-
cipitated for 1 h at −20 °C with 1/10 volume 3 M Na acetate and three
volumes absolute ethanol. After centrifugation the pellets were resus-
pended in 50 μL of H2O.
Probing 32P-End–Labeled fMet–tRNA and 022 mRNA by Hydroxyl Radical
Cleavage. These experiments were carried out as described (51). 30SIC was
allowed to assemble by incubation in 40 μL of 20 mM Na cacodylate (pH 7.7),
50 mM KCl, 10 mM MgCl2, 15 pmol 30S subunit, 30 pmol mRNA, 15 pmol
each of IF1, IF2, and IF3, ∼25,000 cpm 32P-end–labeled fMet–tRNA, and the
indicated amounts of GE81112. After 10 min at 37 °C, H2O2 was added
(0.15% final concentration), and cleavage was started by adding Fe(II)-EDTA
(3 mM final concentration). Cleavage was allowed to proceed for 45 s at
37 °C before the addition of 126 μL quenching solution containing 0.3 M Na
acetate (pH 5.2) in absolute ethanol. The precipitated samples were resus-
pended in H2O, extracted with phenol-chloroform, and reprecipitated with
cold 0.3 M Na acetate (pH 5.2) in absolute ethanol. The cleavage products
then were resuspended in 5 μL 8 M urea containing loading dye and were
analyzed on 10% PAGE in 8 M urea in parallel with an RNase T1-digested
sample and an alkaline-digested ladder (51). The gel was dried, and the
radioactivity therein was detected and quantified by a Bio-Rad model GS-
250 molecular imager. Hydroxyl radical cleavage of 002 mRNA, 022 mRNA,
and 003 mRNA was performed on 30SIC prepared by incubation in 50 μL of
20 mM Na cacodylate (pH 7.7) buffer, 50 mM KCl, 10 mMMgCl2, 40 pmol 30S
subunit, 5 pmol mRNA, 40 pmol each of IF1, IF2, and IF3, 40 pmol fMet–
tRNA, and the indicated amounts of GE81112. After 10 min incubation at
37 °C, H2O2 (0.075% final concentration) was added, and cleavage was
started by adding Fe(II)-EDTA (3 mM final concentration). After 45 s at 37 °C,
155 μL of quenching solution containing 0.3 M Na acetate (pH 5.2) in ab-
solute ethanol was added, and the precipitated samples were resuspended
in H2O, extracted with phenol, phenol-chloroform, and chloroform, and fi-
nally precipitated with cold 0.3 M Na acetate (pH 5.2) in absolute ethanol.
The precipitated reaction products, resuspended in 3 μL of sterile H2O, then
were subjected to primer extension analysis at 42 °C for 45 min in 15 μL of
reaction mixtures containing 0.33 mM dNTP, 0.13 units of avian myeloblastosis
virus reverse transcriptase (Roche), and 0.1 pmol of 32P-labeled oligonucleotide
no. 022: 5′-AGCTTGCATGCCTGC-3′, which anneals 38 nucleotides downstream
of the initiation triplet of the mRNAs. The reactions products then were pre-
cipitated by the addition of 0.3 M Na acetate (pH 5.2) in absolute ethanol,
resuspended in 8 M urea loading dye, and analyzed on 8% PAGE in 8 M urea
in parallel with a dideoxy chain termination sequencing reaction (11). The gels
were dried, and the radioactivity therein was detected and quantified by a
Bio-Rad model GS-250 molecular imager.
Structure Determination by X-Ray Crystallography. The 30S ribosomal subunit
was purified from T. thermophilus HB8 (52) and crystallized (19, 52) in the
presence of an RNA oligonucleotide (Dharmacon) with the sequence
5′-GAAAGGAGG-3′, which is complementary to the anti–Shine–Dalgarno se-
quence present at the 3′ end of the T. thermophilus 16S rRNA, as described
previously (7, 53). Crystals were soaked overnight with 45 μM GE81112 and
were flash-frozen in liquid nitrogen. Diffraction data were collected at the
X06SA beamline of the Swiss Light Source and were processed with the XDS
(54) and CCP4 (55) program packages. The native structure of the 30S sub-
unit [Protein Data Bank (PDB) ID code: 2ZM6] was refined against the
structure factor amplitudes of the 30S–GE81112 complex using the PHENIX
program package (56). Conformational changes in the ribosomal binding
pocket of GE81112 were detected by the difference Fourier technique
where, specifically, we used a bulk solvent modeling protection approach as
previously described (20, 21). Subsequently, GE81112 and the described
conformational changes were modeled into the residual electron density
using Coot (57), and the resulting 30S–GE81112 structure was further refined
to convergence. For the calculation of the free R-factor, 5% of the data were
omitted throughout refinement. Crystallographic data of the fully refined
structure are shown in Table 1. Figures containing structural formula and 3D
structures were illustrated with MarvinSketch (ChemAxon) and PyMOL (58),
respectively. rRNA residues were numbered according to the E. coli scheme,
and helices are indicated using standard nomenclature (59) throughout
the article.
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